CEREBROVASCULAR ACCIDENT ASSOCIATED HEMIPARESIS AND HEMIPLEGIA: COPING STRATEGIES AND SUPPORT
AbstractBackground: Cerebrovascular Accident (CVA) ranks as the third leading cause of mortality globally and contributes significantly to chronic adult disabilities. Hemiparesis, the most prevalent post-stroke mobility impairment, affects approximately 75% of stroke survivors, substantially reducing their quality of life. This study aims to investigate CVA-associated Hemiparesis and Hemiplegia, focusing on management strategies to improve functional outcomes. Methods: A prospective observational study was conducted over six months include CVA patients aged > 30 years with CVA associated Hemiparesis or Hemiplegia, comprising both hospitalized and follow-up outpatient cases. Data were collected from patient case records and structured questionnaires, covering demographic details, type of stroke, drug therapy, type of physiotherapy received, adherence to post-discharge physiotherapy, and its impact on recovery. After completion of the study, the data were systematically analyzed and results were interpreted. Results: Hypertension was identified as the most common risk factor (39%), and statins were the most frequently prescribed pharmacological treatment (31%). Constraint-induced movement Therapy (CIMT) was implemented in 54% of cases, and regular post-discharge physiotherapy was undertaken by 84% of patients. Outcomes revealed that 82% of patients demonstrated significant improvements in motor function, while 18% showed no notable recovery. Integrated management combining pharmacological interventions and physiotherapy was crucial in enhancing neuroplasticity and mobility. Conclusion: A holistic approach, including timely intervention, targeted drug therapy, and structured rehabilitation, is vital for managing CVA-associated Hemiparesis and Hemiplegia. This multidisciplinary strategy improves functional abilities and overall quality of life, emphasizing the importance of early and sustained rehabilitation in stroke care.
Article Information
19
1329-1334
513 KB
43
English
IJPSR
Karra Geetha *, G. Sasanka, Meraj Unnisa Banu, S. Pridvineel Reddy and T. Rama Rao
Department of Pharmaceutics, CMR College of Pharmacy, Hyderabad, Telangana, India.
geetabiokarra@gmail.com
16 December 2024
27 December 2024
31 December 2024
10.13040/IJPSR.0975-8232.16(5).1329-34
01 May 2025